VIRACTA THERAPEUTICS INC
VIRACTA THERAPEUTICS INC logo
VIRX

VIRACTA THERAPEUTICS INC (VIRX)

$2.121.44%

Market is closed
– opens on 8 PM, 30 Jan 2023
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$2.03
Day's Range
$2.17
$1.21
52-Week Range
$5.75
1 month return68.25%
3 month return46.06%
1 year return20.9%
5 year return86.5%

Analyst Recommendation

based on 11 analysts ratings

Buy
90%
Buy
9%
Hold
0%
Sell

Based on 11 Wall street analysts offering stock ratings for VIRACTA THERAPEUTICS INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 607.55%

Current

$2.12

Target

$15.0

Recommendation Trend

Based on 11 analyst

Current1M Ago3M Ago
Buy
10
4
10
Hold
1
0
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization81.0M
Book Value$1.65
Dividend Share0.0
Dividend Yield0.0%
Earnings Per Share (EPS)1.49
PE Ratio1.42
Wall Street Target Price15.0

Valuation

Trailing PE1.42
Forward PE0.0
Price/Book (mrq)1.18
Enterprise Value7.4M
Enterprise Value/Revenue0.0
Enterprise Value/Ebitda-0.15

Technicals

50 Day MA2.02
200 Day MA3.18

Institutional Holdings

Bvf Inc

9.46%

Citadel Advisors Llc

4.09%

Vanguard Group Inc

2.92%

Rubric Capital Management LP

2.6%

LAURION CAPITAL MANAGEMENT LP

1.83%

Samsara BioCapital, LLC

1.81%

Company Information

Viracta is a precision oncology company targeting virus-associated malignancies. The Company's proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in a Phase 2 clinical trial for EBV-positive lymphomas. Viracta is pursuing application of this inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, and other virus-related cancers.
OrganizationVIRACTA THERAPEUTICS INC
Employees33
CEOMr. Daniel R. Chevallard
IndustryHealthcare

Discover more

Frequently Asked Questions

What is VIRACTA THERAPEUTICS INC share price today?

Can Indians buy VIRACTA THERAPEUTICS INC shares?

How can I buy VIRACTA THERAPEUTICS INC shares from India?

Can Fractional shares of VIRACTA THERAPEUTICS INC be purchased?

What are the documents required to start investing in VIRACTA THERAPEUTICS INC stocks?

What are today’s High and Low prices of VIRACTA THERAPEUTICS INC?

What are today’s traded volumes of VIRACTA THERAPEUTICS INC?

What is today’s market capitalisation of VIRACTA THERAPEUTICS INC?

What is the 52 Week High and Low Range of VIRACTA THERAPEUTICS INC?

How much percentage VIRACTA THERAPEUTICS INC is down from its 52 Week High?

How much percentage VIRACTA THERAPEUTICS INC is up from its 52 Week low?

What are the historical returns of VIRACTA THERAPEUTICS INC?

Who is the Chief Executive Officer (CEO) of VIRACTA THERAPEUTICS INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*